SPDR Advertisement SureTrader SureTrader SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 7/7/2015 1:51:35 PM - Followers: 599 - Board type: Free - Posts Today: 44

Cellceutix Corporation (CTIX) 


Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


Management:   http://cellceutix.com/team/
The above link is kept updated.

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
Product Pipeline:  http://cellceutix.com/pipeline/


Recent News and Press Releases: 

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)


Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections


SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:


Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet



Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports 06/15/2015 07:00:00 AM
CTIX News: Special Profile & Four Companies Where Investors are Anticipating Success 06/03/2015 07:00:00 AM
CTIX News: *Special Analyst Alert* and 4 Companies that are Worth a Look 05/13/2015 07:00:00 AM
CTIX News: Quarterly Report (10-q) 05/11/2015 02:03:16 PM
CTIX News: Current Report Filing (8-k) 04/27/2015 07:34:19 AM
#109053  Sticky Note Corporate fact sheet from June 2015: KarinCA 06/22/15 01:09:55 PM
#106046  Sticky Note http://cellceutix.com/wp-content/uploads/2015/06/Cellceutix-Fact-Sheet-June-2015-flattened-1.pd DoubleJ23 06/02/15 01:06:23 PM
#105928  Sticky Note ASCO 2015: New Information, New Data, and 3rd BigKahuna 06/01/15 07:30:59 PM
#92697  Sticky Note upcoming catalysts slcimmuno 02/26/15 09:18:08 AM
#87958  Sticky Note Cellceutix Reports Spleen Lesion 'Disappears' in Patient With starbuxsux 01/20/15 08:25:55 AM
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#110411   lol. K maybe you weren't being sarcastic..... Go CTIX! TheHound 07/07/15 01:51:35 PM
#110410   Thanks......buying and holding onto Apple and a few Fletch 07/07/15 01:43:23 PM
#110409   I'm pretty sure he was being sarcastic lol. TheHound 07/07/15 01:40:17 PM
#110408   Congrats Fletch. Hope you are loaded to the Tails 07/07/15 01:23:53 PM
#110407   I only watch level II when in trading KarinCA 07/07/15 01:20:53 PM
#110406   On mobile and can't check easily, but, I KarinCA 07/07/15 01:18:42 PM
#110405   Just because you ignore the sun will not Amatuer17 07/07/15 01:11:01 PM
#110404   Thanks! I do what I can. I figure TheDane 07/07/15 12:57:51 PM
#110402   Stop pumping! Sincerely, Steinvid. sox040713 07/07/15 12:44:15 PM
#110401   Dane, too bad there's no "like button" or sox040713 07/07/15 12:43:10 PM
#110400   I'm just bitching bout a fact compared to believer20 07/07/15 12:29:51 PM
#110398   How do you see through that cloud of TheDane 07/07/15 12:07:53 PM
#110397   This could be play on words by Leo In Amatuer17 07/07/15 11:41:52 AM
#110396   im thinking th same doubleupZW 07/07/15 11:23:03 AM
#110395   Down boy, down Steinvid 07/07/15 11:11:25 AM
#110394   You've heard of the Pump n' Dump. F1ash 07/07/15 11:02:20 AM
#110393   KarinCA, i know you watch L2 sometimes...what is DaubersUP 07/07/15 10:52:39 AM
#110392   Pending status since early Feb... There has to Rdunn88 07/07/15 10:40:34 AM
#110391   phase 3 trumps all this nonsense. stop doubleupZW 07/07/15 10:21:35 AM
#110390   All this b#tch$n and we are a week doubleupZW 07/07/15 10:20:09 AM
#110389   The application is in pending status. KarinCA 07/07/15 10:19:59 AM
#110388   Not much happening in CTIX world these days. Rdunn88 07/07/15 10:11:11 AM
#110387   Real nice watching 5-9k chunks of value evaporate believer20 07/07/15 10:03:24 AM
#110386   Wrong. B approval for phase 3 (which can NanoEngineer 07/07/15 10:01:05 AM
#110385   So you seriously don't think the outcome of TheHound 07/07/15 09:59:14 AM
#110383   Let's see if this sled holds at $2.40. TheBunny 07/07/15 09:51:34 AM
#110380   2015 vs 2016. Now resigning myself to To infinity and beyond! 07/07/15 09:40:33 AM
#110379   Mornin BD. could happen... i don't see us TheHound 07/07/15 09:23:21 AM
#110378   If you look on the chart I posted TheHound 07/07/15 09:15:30 AM
#110377   Ha, the bollinger part wasn't the question, it Drano 07/07/15 08:50:30 AM
#110376   BB= Bollinger Bands, named after a guy John Bollinger lousy engineer 07/07/15 08:14:00 AM
#110375   Whoops Good point but this is for the diabetic Echo20 07/07/15 08:13:18 AM
#110374   Not sure I'm following you Hound. I BooDog 07/07/15 07:41:02 AM
#110373   Ha, like the analogy! EasyRider 07/07/15 07:23:18 AM
#110372   Think surfing. TheDane 07/07/15 07:17:57 AM
#110371   What does that mean in English? Drano 07/07/15 02:12:31 AM
#110370   Riding the BB wave. I see a huge TheHound 07/07/15 12:55:16 AM
#110369   Corporate fact sheet from June 2015: http://www.cellceutix.com/wp-content/uplo TheHound 07/07/15 12:14:58 AM
#110368   "but this trades on an off market". People TheHound 07/07/15 12:00:40 AM
#110367   yes as did I at 2.48 Tried 2.46 jsc52033 07/06/15 11:29:20 PM
#110366   You may want to tell him human trials KarinCA 07/06/15 06:29:34 PM
#110365   Echo i think Brilacidin for diabetic foot is Whoops 07/06/15 06:04:57 PM
#110364   Luxe This is for the bricilidin diabetic ulcer trial Echo20 07/06/15 05:47:28 PM
#110363   Whoops The photo did not ho in well. This guy Echo20 07/06/15 05:43:00 PM
#110362   The Dane Absolutly real and true. He wants to be Echo20 07/06/15 05:39:25 PM
#110361   Here is a picture of Al m. who Echo20 07/06/15 05:19:20 PM
#110360   Please clarify? Whoops 07/06/15 04:56:46 PM
#110359   For real? TheDane 07/06/15 04:34:10 PM
#110358   There is a company called Novabay Pharma (NBY) luxe 07/06/15 04:24:21 PM
#110357   Nice recovery. TheHound 07/06/15 04:23:18 PM